Klorzoxazon Dak

Chlorzoxazone, the active ingredient in Klorzoxazon Dak, is a muscle relaxant presented as an oral tablet for systemic use. It is employed to relieve muscle spasm and associated musculoskeletal pain in adult patients.

GNH USA supplies Klorzoxazon Dak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Chlorzoxazone acts on skeletal muscle spasm and related pain conditions.

- Muscle spasm: reduces painful involuntary muscle contractions and improves mobility. - Acute musculoskeletal pain: alleviates pain associated with strains, sprains, and low‑back discomfort. - Chronic musculoskeletal disorders: provides adjunctive relief when combined with physical therapy and other analgesics.

Adverse reactions may occur with chlorzoxazone therapy.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: light‑headed sensation, especially upon standing. - Nausea: upset stomach or urge to vomit. - Headache: mild to moderate cranial pain. - Gastrointestinal upset: abdominal discomfort or dyspepsia. - Fatigue: reduced energy levels.

Serious or Rare Side Effects: - Hepatotoxicity: signs of liver injury such as jaundice or elevated enzymes. - Severe skin reactions: rash, Stevens‑Johnson syndrome, or toxic epidermal necrolysis. - Blood dyscrasias: unexplained bruising, anemia, or leukopenia. - Anaphylaxis: sudden severe allergic reaction with airway compromise. - Agranulocytosis: marked reduction in white blood cells, increasing infection risk.

Before initiating chlorzoxazone therapy, consider the following safety measures.

- Pregnancy: safety not established; avoid unless clearly needed. - Liver disease: use with caution and monitor hepatic function. - Alcohol consumption: may potentiate central nervous system depression. - Elderly patients: increased susceptibility to sedation and falls; start at lower doses. - Concomitant CNS depressants: monitor for additive sedation effects. - Store at ambient temperature: keep in the original pack, protect from moisture.

Chlorzoxazone may interact with several drug classes, requiring vigilance.

Major Interactions (Avoid): - CYP2E1 inhibitors (e.g., disulfiram): can increase chlorzoxazone plasma levels. - CNS depressants (e.g., opioids, benzodiazepines): additive sedation and respiratory depression. - Alcohol: enhances central nervous system depression.

Moderate Interactions (Monitor Closely): - CYP2E1 inducers (e.g., rifampin): may reduce therapeutic effect. - Anticoagulants (e.g., warfarin): potential for increased bleeding risk. - Antihistamines: may heighten drowsiness and dizziness.